Moreover, a clinical trial of receptor tyrosine kinase-like orphan receptor 1 (ROR1) CAR-T cells overexpressing c-Jun revealed a potential risk of treatment-related pneumonia in cancer patients with lung metastases. Here, ROR1 is linked to susceptibility to pneumonia measurement.